Navigation Links
Cato Research Celebrates 25 Years of Successful Life Science Research and Development
Date:9/18/2013

Durham, NC (PRWEB) September 18, 2013

Cato Research (CATO) celebrates 25 years of dedicated service to the life science industry. CATO has navigated decades of successful health care research and development, bringing products to the market that ultimately may help those who need them the most.

Headquartered in the Research Triangle Park of North Carolina, CATO is a global, competitive contract research organization that includes an investment arm, Cato BioVentures. Together, CATO and Cato BioVentures have helped biotech companies, pharmaceutical companies, and investors develop their products and bring them to market. CATO has a proven track record of effective collaboration, saving time and reducing cost without jeopardizing product quality while meeting the clinical and regulatory project challenges. The combination of these attributes and capabilities makes for many successful years of business.

“It is truly rewarding to be able to reflect over the past 25 years, cherishing the relationships we have built, and proud of the growth and success we have experienced. Most important to us are the patients we have been able to help by bringing products to the market that have made a difference to their lives. We are thankful and look forward to servicing this industry many more years to come,” says Lynda Sutton, President and cofounder of Cato Research and Cato BioVentures.

Cofounded in 1988 by Allen Cato, M.D., Ph.D., and Lynda Sutton, CATO will celebrate its 25th year by holding several wine tastings throughout the United States at its many office locations. These events will include evenings filled with highly rated wines and delightful hors d'oeuvres, accompanied with lots of mingling. The celebration begins in Boston, Massachusetts, and will conclude in Durham, North Carolina. More information is detailed below.

Celebrate with CATO at the following locations and dates:

Cato Research Boston office
Boston, MA USA
Wednesday, 18 September 2013

Cato Research Washington, D.C. office
Washington, D.C. USA
Tuesday, 08 October 2013

Cato Research San Diego office
San Diego, CA USA
Tuesday, 15 October 2013

FINALE: Cato Research Durham office
Durham, NC USA
Tuesday, 29 October 2013

More information and registration links can be found at:
http://www.cato.com/marketing/2013/25-Year-Wine-Tasting_Cato-Research-Boston2013.html

About Cato BioVentures
Cato BioVentures is the venture capital affiliate of Cato Research, a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepreneurs, academic institutions, and a broad base of biotechnology and pharmaceutical companies to advance a robust portfolio of successful product development programs. Through strategic CRO service agreements with Cato Research, Cato BioVentures has invested its CRO Service Capital™ in innovative therapeutics, medical devices, and stem cell technologies that improve the pharmaceutical industry’s research and development productivity. If strategic outsourcing for development, regulatory, and clinical support is a core component of a company’s business plan, then Cato BioVenture’s investment model can make a positive difference in that company’s overall success.

About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. With a staff of approximately 300 and offices located in the United States, Europe, Canada, Israel, and South Africa, Cato Research consistently demonstrates an unsurpassed level of responsiveness, flexibility, attention to detail, and passion for bringing its clients’ products to market with speed and cost-effectiveness.

For more information, please contact:

Cato Research
Phone: 919-361-2286
http://www.cato.com
# # #

Read the full story at http://www.prweb.com/releases/2013/9/prweb11133227.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UCLA researchers smartphone microscope can detect a single virus, nanoparticles
2. Lisa Niemi Swayze And The Pancreatic Cancer Action Network Join More Than 160 Organizations In Asking Congress To Protect Medical Research Funding
3. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
4. Quorum IRB Board Chair to Speak at South Korean Research Summit
5. MarketResearchReports.Biz: China Orthopedic Instrument Industry Report, 2013 - 2015 - New Industry Report
6. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
7. Crowdfunding Expert Kendall Almerico Discusses Scientists Using Crowdfunding to Replace Research Grants
8. Intrexon and Rentokil Enter into Research and Development Agreement to Explore a New Generation of Highly-Effective, Sustainable Pest Controls
9. Elsevier and Australasian Research Management Society Honor Promising Young Scientists for their Work in Academic Research
10. Hydrofluoric & Aminoacetic Acid (Gly) Industry 2013 China and Global Analysis in New Research Report at Deepresearchreports.com
11. Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... June 28, 2017 Michael Zasloff , ... University School of Medicine, and Founder, Chairman and CEO ... study that has helped clarify the function of alpha-Synuclein ... other neurodegenerative diseases. Denise Barbut , MD, FRCP, ... was senior co-author of the study. Published ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... three research projects accepted for presentation at the 33rd Annual Meeting of the ... – including some of the world’s top thought leaders in reproductive medicine – ...
(Date:6/28/2017)... and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics computational fluid ... enable automated product design exploration and optimization. STAR-CCM+ version 12.04 introduces Design ...
(Date:6/28/2017)... NC (PRWEB) , ... June 28, 2017 , ... Studies ... might lead to an effective treatment for Parkinson’s disease. But what has not been ... should take place to gain the best results. , A new study coming out ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):